Antibody dependent, complement mediated liver uptake of liposomes containing GM1
- PMID: 8592685
- DOI: 10.1023/a:1016286310475
Antibody dependent, complement mediated liver uptake of liposomes containing GM1
Abstract
Purpose: We have previously reported that GM1 exhibits an opposite effect on regulating liposome circulation time in mice and rats (Liu et al. Pharm. Res. Vol. 12:508-512 (1995)). Inclusion of GM1 into liposomes significantly prolongs liposome circulation time in mice, while it dramatically decrease the blood half life and increases liver uptake of liposomes in rats. The purpose of this study was to elucidate the mechanism that underlies this phenomenon.
Methods: Single-pass liver perfusion in vitro and complement mediated liposome lysis assay was used.
Results: Serum appeared to play an important role in determining the liver uptake of GM1 liposomes. Specifically, rat serum enhanced the uptake of GM1-containing liposomes by the perfused liver. Such activity was also found in human and bovine serum, but not in mouse serum. Taking human serum as an example, we demonstrated that such serum activity can be blocked by EDTA and EGTA/Mg2+. Antibodies against human IgM and the third component of complement system (C3) also inhibited serum activity.
Conclusions: The presence of naturally occurring anti-GM1 antibodies in rats, through the activation of the classic pathway of complement system, is likely the cause of rapid blood clearance of GM1-liposomes. The third component of complement is likely to serve as the opsonin that is directly involved in mediating liposome clearance.
Similar articles
-
Liposome clearance from blood: different animal species have different mechanisms.Biochim Biophys Acta. 1995 Dec 13;1240(2):277-84. doi: 10.1016/0005-2736(95)00184-0. Biochim Biophys Acta. 1995. PMID: 8541299
-
Monosialoganglioside GM1 shortens the blood circulation time of liposomes in rats.Pharm Res. 1995 Apr;12(4):508-12. doi: 10.1023/a:1016289526578. Pharm Res. 1995. PMID: 7596984
-
Anti-GM1 ganglioside IgM-antibodies present in human plasma: affinity and biological activity changes in a patient with neuropathy.J Neurosci Res. 1998 Jan 15;51(2):237-42. doi: 10.1002/(SICI)1097-4547(19980115)51:2<237::AID-JNR12>3.0.CO;2-5. J Neurosci Res. 1998. PMID: 9469577
-
Liposome clearance.Biosci Rep. 2002 Apr;22(2):197-224. doi: 10.1023/a:1020134521778. Biosci Rep. 2002. PMID: 12428901 Review.
-
Liposome opsonization.J Liposome Res. 2005;15(1-2):109-39. doi: 10.1081/lpr-64971. J Liposome Res. 2005. PMID: 16194930 Review.
Cited by
-
Designing of 'intelligent' liposomes for efficient delivery of drugs.J Cell Mol Med. 2002 Oct-Dec;6(4):465-74. doi: 10.1111/j.1582-4934.2002.tb00450.x. J Cell Mol Med. 2002. PMID: 12611636 Free PMC article. Review.
-
Surface engineering of liposomes for stealth behavior.Pharmaceutics. 2013 Oct 25;5(4):542-69. doi: 10.3390/pharmaceutics5040542. Pharmaceutics. 2013. PMID: 24300562 Free PMC article.
-
Efficient hepatic delivery of drugs: novel strategies and their significance.Biomed Res Int. 2013;2013:382184. doi: 10.1155/2013/382184. Epub 2013 Oct 28. Biomed Res Int. 2013. PMID: 24286077 Free PMC article. Review.
-
C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.ACS Nano. 2018 Jun 26;12(6):5834-5847. doi: 10.1021/acsnano.8b01806. Epub 2018 May 23. ACS Nano. 2018. PMID: 29750504 Free PMC article.
-
Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.Int J Pharm. 2013 Mar 25;446(1-2):119-29. doi: 10.1016/j.ijpharm.2013.02.026. Epub 2013 Feb 16. Int J Pharm. 2013. PMID: 23419666 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous